Literature DB >> 25035325

Strain Kaplan of Pseudorabies Virus Genome Sequenced by PacBio Single-Molecule Real-Time Sequencing Technology.

Dóra Tombácz1, Donald Sharon2, Péter Oláh1, Zsolt Csabai1, Michael Snyder2, Zsolt Boldogkői3.   

Abstract

Pseudorabies virus (PRV) is a neurotropic herpesvirus that causes Aujeszky's disease in pigs. PRV strains are widely used as transsynaptic tracers for mapping neural circuits. We present here the complete and fully annotated genome sequence of strain Kaplan of PRV, determined by Pacific Biosciences RSII long-read sequencing technology.
Copyright © 2014 Tombácz et al.

Entities:  

Year:  2014        PMID: 25035325      PMCID: PMC4102862          DOI: 10.1128/genomeA.00628-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Pseudorabies virus (PRV), also known as Aujeszky’s disease virus or suid herpesvirus 1, a member of the Alphaherpesvirinae subfamily, causes significant abortion and morbidity in pigs, the natural host of the virus (1). PRV is a useful model organism for studies of the pathogenesis of herpesviruses. The genetically modified strains are powerful tracers for mapping neuronal circuits (2–6), are tools in gene and cancer therapy (7), and serve as viral vectors for gene delivery into mammalian neurons (3, 4) and cardiomyocytes (8); PRVs have also been employed as live vaccines against Aujeszky’s disease (9–11). Further, attenuated vaccine strains of PRV are valuable models for novel vaccine development against varicella-zoster virus (VZV) and herpes simplex virus 1 and 2 (HSV-1 and HSV-2, respectively) (12). The currently available genome sequences of PRV contain several discrepancies, mainly in intergenic repetitive regions (GenBank accession no. JF797218.1), and the totally annotated version of genome sequence is a composite of six different PRV strains (GenBank accession no. NC_006151.1). We have sequenced the PRV Kaplan genome with Pacific Biosciences single-molecule long-read sequencing technology (Pacific Biosciences, Menlo Park, CA, USA) in order to upgrade the draft sequences, reconstruct the GC-rich and repetitive regions of the genome, and extract epigenetic information. The availability of the completely annotated genome and the single-base resolution methylation map of strain Kaplan will aid in understanding the control of viral gene expression at different levels. Investigations of the PRV genome and gene functions are expected to result in the development of effective vaccines and direct practical applications in gene, cancer, and antiviral therapies. Sequencing of purified virion DNA was carried out on the Pacific Biosciences RSII sequencer. SMRTbell template libraries were prepared from the DNA, as previously described (13, 14), using standard protocols for 6-kb and 20-kb library preparation. Sequencing was performed in five single-molecule real-time (SMRT) cells with P5 DNA polymerase and C3 chemistry (P5-C3) yielding a total of 78,111 reads and an extremely high coverage (1,200×) throughout the genome. The sequencing reads were processed and mapped to the respective reference sequences with the BLASR mapper (https://github.com/PacificBiosciences/blasr) and the Pacific Biosciences SMRT Analysis pipeline (https://github.com/PacificBiosciences/SMRT-Analysis/wiki/SMRT-Pipe-Reference-Guide-v2.0) using the standard mapping protocol. The protein-coding genes were predicted by GATU (15). Manual annotation was used to identify other genomic features. Annotation of a previously unknown noncoding RNA (named Close to OriL [CTO]), a newly discovered splice site of the early protein 0 gene, and new isoforms of 11 protein-coding genes are based on RNAseq data (our unpublished data). MicroRNA (miRNA) annotation was based on the precursor miRNAs found in strains NIA-3 and Ea. The complete genome of strain Kaplan of PRV is characterized as a double-stranded linear DNA composed of 143,423 bp, with an average G+C content of 73.59%. PRV contains 70 protein-coding genes (11 genes have different isoforms), two latency-associated transcripts, and a long noncoding RNA, and its genome predicts 16 miRNAs.

Nucleotide sequence accession number.

The complete genome of strain Kaplan of pseudorabies virus was assigned DDBJ/EMBL/GenBank accession no. KJ717942.
  14 in total

1.  Genetically timed, activity-sensor and rainbow transsynaptic viral tools.

Authors:  Zsolt Boldogkoi; Kamill Balint; Gautam B Awatramani; David Balya; Volker Busskamp; Tim James Viney; Pamela S Lagali; Jens Duebel; Emese Pásti; Dóra Tombácz; Judit S Tóth; Irma F Takács; Brigitte Gross Scherf; Botond Roska
Journal:  Nat Methods       Date:  2009-01-04       Impact factor: 28.547

2.  Calcium imaging of neuronal circuits in vivo using a circuit-tracing pseudorabies virus.

Authors:  Andrea E Granstedt; Bernd Kuhn; Samuel S-H Wang; Lynn W Enquist
Journal:  Cold Spring Harb Protoc       Date:  2010-04

Review 3.  New developments in tracing neural circuits with herpesviruses.

Authors:  C Kay Song; Lynn W Enquist; Timothy J Bartness
Journal:  Virus Res       Date:  2005-08       Impact factor: 3.303

4.  Immunization of pigs with an attenuated pseudorabies virus recombinant expressing the haemagglutinin of pandemic swine origin H1N1 influenza A virus.

Authors:  Katharina Klingbeil; Elke Lange; Jens P Teifke; Thomas C Mettenleiter; Walter Fuchs
Journal:  J Gen Virol       Date:  2014-01-15       Impact factor: 3.891

5.  Oral immunization of wild boar and domestic pigs with attenuated live vaccine protects against Pseudorabies virus infection.

Authors:  Christina Maresch; Elke Lange; Jens P Teifke; Walter Fuchs; Barbara Klupp; Thomas Müller; Thomas C Mettenleiter; Thomas W Vahlenkamp
Journal:  Vet Microbiol       Date:  2012-07-10       Impact factor: 3.293

Review 6.  Gene and cancer therapy--pseudorabies virus: a novel research and therapeutic tool?

Authors:  Zsolt Boldogköi; Antal Nógrádi
Journal:  Curr Gene Ther       Date:  2003-04       Impact factor: 4.391

7.  A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses.

Authors:  Moriah L Szpara; Yolanda R Tafuri; Lance Parsons; S Rafi Shamim; Kevin J Verstrepen; Matthieu Legendre; L W Enquist
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

8.  A dual infection pseudorabies virus conditional reporter approach to identify projections to collateralized neurons in complex neural circuits.

Authors:  J Patrick Card; Oren Kobiler; Ethan B Ludmir; Vedant Desai; Alan F Sved; Lynn W Enquist
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

9.  Characterization of DNA methyltransferase specificities using single-molecule, real-time DNA sequencing.

Authors:  Tyson A Clark; Iain A Murray; Richard D Morgan; Andrey O Kislyuk; Kristi E Spittle; Matthew Boitano; Alexey Fomenkov; Richard J Roberts; Jonas Korlach
Journal:  Nucleic Acids Res       Date:  2011-12-07       Impact factor: 16.971

10.  Genome Annotation Transfer Utility (GATU): rapid annotation of viral genomes using a closely related reference genome.

Authors:  Vasily Tcherepanov; Angelika Ehlers; Chris Upton
Journal:  BMC Genomics       Date:  2006-06-13       Impact factor: 3.969

View more
  16 in total

1.  A pUL25 dimer interfaces the pseudorabies virus capsid and tegument.

Authors:  Yun-Tao Liu; Jiansen Jiang; Kevin Patrick Bohannon; Xinghong Dai; G W Gant Luxton; Wong Hoi Hui; Guo-Qiang Bi; Gregory Allan Smith; Z Hong Zhou
Journal:  J Gen Virol       Date:  2017-10-16       Impact factor: 3.891

2.  Evaluation of the impact of ul54 gene-deletion on the global transcription and DNA replication of pseudorabies virus.

Authors:  Zsolt Csabai; Irma F Takács; Michael Snyder; Zsolt Boldogkői; Dóra Tombácz
Journal:  Arch Virol       Date:  2017-06-02       Impact factor: 2.574

3.  Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2.

Authors:  Ruchi M Newman; Susanna L Lamers; Brian Weiner; Stuart C Ray; Robert C Colgrove; Fernando Diaz; Lichen Jing; Kening Wang; Sakina Saif; Sarah Young; Matthew Henn; Oliver Laeyendecker; Aaron A R Tobian; Jeffrey I Cohen; David M Koelle; Thomas C Quinn; David M Knipe
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

4.  Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.

Authors:  Teru Kanda; Yuki Furuse; Hitoshi Oshitani; Tohru Kiyono
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 5.  Perspectives and Benefits of High-Throughput Long-Read Sequencing in Microbial Ecology.

Authors:  Leho Tedersoo; Mads Albertsen; Sten Anslan; Benjamin Callahan
Journal:  Appl Environ Microbiol       Date:  2021-08-11       Impact factor: 4.792

Review 6.  Advanced molecular surveillance of hepatitis C virus.

Authors:  Livia Maria Gonçalves Rossi; Alejandro Escobar-Gutierrez; Paula Rahal
Journal:  Viruses       Date:  2015-03-13       Impact factor: 5.048

7.  Long-read sequencing of the human cytomegalovirus transcriptome with the Pacific Biosciences RSII platform.

Authors:  Zsolt Balázs; Dóra Tombácz; Attila Szűcs; Michael Snyder; Zsolt Boldogkői
Journal:  Sci Data       Date:  2017-12-19       Impact factor: 6.444

8.  Multi-Platform Sequencing Approach Reveals a Novel Transcriptome Profile in Pseudorabies Virus.

Authors:  Norbert Moldován; Dóra Tombácz; Attila Szűcs; Zsolt Csabai; Michael Snyder; Zsolt Boldogkői
Journal:  Front Microbiol       Date:  2018-01-22       Impact factor: 5.640

9.  Full-Length Isoform Sequencing Reveals Novel Transcripts and Substantial Transcriptional Overlaps in a Herpesvirus.

Authors:  Dóra Tombácz; Zsolt Csabai; Péter Oláh; Zsolt Balázs; István Likó; Laura Zsigmond; Donald Sharon; Michael Snyder; Zsolt Boldogkői
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

10.  Long-Read Isoform Sequencing Reveals a Hidden Complexity of the Transcriptional Landscape of Herpes Simplex Virus Type 1.

Authors:  Dóra Tombácz; Zsolt Csabai; Attila Szűcs; Zsolt Balázs; Norbert Moldován; Donald Sharon; Michael Snyder; Zsolt Boldogkői
Journal:  Front Microbiol       Date:  2017-06-20       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.